Aventis Triumphs In Patent Suit Over ALS Drug
A Delaware federal court has buried Impax Laboratories Inc.'s efforts to market a generic version of a Sanofi-Aventis U.S. LLC treatment for Lou Gehrig's disease by validating a patent for the...To view the full article, register now.
Already a subscriber? Click here to view full article